Role of Non-coding RNAs in Acute Myeloid Leukemia

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Acute myeloid leukemia (AML) disproportionately affects the elderly, with complex and incompletely understood etiology.
• Non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), are increasingly implicated in AML leukemogenesis.
• Altered ncRNA expression impacts critical cellular processes like proliferation and cell death, offering potential as diagnostic and prognostic biomarkers.

Purpose of the Study:

• To review the significant role of long non-coding RNAs (lncRNAs) in acute myeloid leukemia (AML).
• To elucidate how lncRNAs influence prognostic predictions and diagnostic accuracy in AML.
• To provide a comprehensive understanding of lncRNA involvement in the AML disease landscape.

Main Methods:

• Literature review focusing on non-coding RNAs in acute myeloid leukemia.
• Analysis of current research on the diagnostic and prognostic implications of ncRNAs, particularly lncRNAs.
• Synthesis of information regarding the mechanisms by which lncRNAs contribute to leukemogenesis.

Main Results:

• ncRNAs are integral to AML pathogenesis, affecting cell division, proliferation, and apoptosis.
• Specific ncRNAs, especially lncRNAs, demonstrate potential as prognostic biomarkers for AML.
• Altered expression patterns of ncRNAs provide valuable information for AML diagnosis, treatment, and patient follow-up.

Conclusions:

• The identification and study of ncRNAs, particularly lncRNAs, have opened new therapeutic and diagnostic avenues for AML.
• lncRNAs significantly influence prognostic predictions and diagnostic accuracy in AML.
• Further research into lncRNAs is essential for advancing AML management and patient outcomes.